1. Home
  2. CACI vs LEGN Comparison

CACI vs LEGN Comparison

Compare CACI & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CACI
  • LEGN
  • Stock Information
  • Founded
  • CACI 1962
  • LEGN 2014
  • Country
  • CACI United States
  • LEGN United States
  • Employees
  • CACI N/A
  • LEGN N/A
  • Industry
  • CACI EDP Services
  • LEGN Biotechnology: Pharmaceutical Preparations
  • Sector
  • CACI Technology
  • LEGN Health Care
  • Exchange
  • CACI Nasdaq
  • LEGN Nasdaq
  • Market Cap
  • CACI 9.2B
  • LEGN 7.8B
  • IPO Year
  • CACI 1979
  • LEGN 2020
  • Fundamental
  • Price
  • CACI $411.52
  • LEGN $34.51
  • Analyst Decision
  • CACI Buy
  • LEGN Strong Buy
  • Analyst Count
  • CACI 11
  • LEGN 13
  • Target Price
  • CACI $521.20
  • LEGN $81.54
  • AVG Volume (30 Days)
  • CACI 272.6K
  • LEGN 1.5M
  • Earning Date
  • CACI 01-22-2025
  • LEGN 11-12-2024
  • Dividend Yield
  • CACI N/A
  • LEGN N/A
  • EPS Growth
  • CACI 22.78
  • LEGN N/A
  • EPS
  • CACI 20.19
  • LEGN N/A
  • Revenue
  • CACI $7,866,574,000.00
  • LEGN $520,183,000.00
  • Revenue This Year
  • CACI $13.33
  • LEGN $120.77
  • Revenue Next Year
  • CACI $6.82
  • LEGN $68.54
  • P/E Ratio
  • CACI $20.57
  • LEGN N/A
  • Revenue Growth
  • CACI 13.24
  • LEGN 122.96
  • 52 Week Low
  • CACI $314.06
  • LEGN $32.66
  • 52 Week High
  • CACI $588.26
  • LEGN $70.13
  • Technical
  • Relative Strength Index (RSI)
  • CACI 27.27
  • LEGN 32.57
  • Support Level
  • CACI $400.00
  • LEGN $32.66
  • Resistance Level
  • CACI $418.97
  • LEGN $43.96
  • Average True Range (ATR)
  • CACI 12.44
  • LEGN 1.94
  • MACD
  • CACI -1.99
  • LEGN -0.64
  • Stochastic Oscillator
  • CACI 22.82
  • LEGN 16.47

About CACI CACI International Inc.

CACI International Inc is an information solutions and services provider, offering information solutions and services to its customers. The company's primary customers are agencies and departments of the U.S. government, which account for the vast majority of the firm's revenue. It provides information solutions and services supporting national security missions and government modernization for intelligence, defense, and federal civilian customers. Some of the services provided by the company are functional software development, data, and business analysis, IT operations support, naval architecture, and life cycle support intelligence among others. The company's operating segments are; Domestic operations and International operations. It derives key revenue from the Domestic segment.

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Share on Social Networks: